aminomethyl] pyridine. To a solution of 4-chloro-2,6-bis(bromomethyl)pyridine (724 mg, 2.4 mmol) in anhydrous acetonitrile (30 mL) was added di-tert-butyl iminodiacetate (1.19 g, 4.8 mmol) then sodium carbonate (2.60 g, 24.5 mmol). The resulting suspension was stirred at room temperature for 24 hours then filtered. The solvent was evaporated under reduced pressure and the oily residue was taken up with 30 mL of chloroform. The solution was washed with water (2x15 mL), dried over MgSO 4 then concentrated to yield a yellow viscous oil (1.46 g, 96%) . This material was used without further purification. R f : 0.40 (silica, ethyl acetate/cyclohexane: 1/3).
1 H NMR (400 MHz, DMSO-d 6 )  (ppm): 7.53 (2H, s), 3.89 (4H, s), 3.41 (8H, s), 1.39 (18H, s).
13 C NMR (100 MHz, DMSO-d 6 )  (ppm): 169.8, 160.8, 143.7, 120.4, 80.1, 58.8, 55.3, 27.6 . IR (oil)  (cm -1 ): 2978, 1740, 1570, 1369, 1219, 1148, 991, 853, 745 . HRMS (ES+): calcd for C 31 H 51 N 3 O 8 Cl [M+H] + : 628.3365, found 628.3382. b) 4- amino methyl]pyridine. To a solution of 4-chloro-2,6-bis[N,N-bis(tert-butoxycarbonylmethyl) aminomethyl]pyridine (1.50 g, 2.4 SI 3 mmol) in anhydrous DMF (35 mL) was added NaN 3 (1.55 g, 24 mmol) then NBu 4 HSO 4 (163 mg, 0.48 mmol). The resulting suspension was heated at 85°C for 8h and further stirred at room temperature during 16 h. Water (60 mL) was added before extraction with tertbutylmethylether (2×60 mL). The combined organic phases were dried over MgSO 4 2978, 2114, 1740, 1593, 1369, 1223, 1146. c) 4-azido-2,6-bis[N,N-bis(carboxymethyl) aminomethyl] pyridine•4/3 trifluoroacetic acid (TFA) . To a solution of 4-azido-2,6-bis[N,N-bis(tert-butoxycarbonylmethyl)aminomethyl] pyridine (120 mg, 0.19 mmol) in dichloromethane (2 mL) was added at 0°C trifluoroacetic acid (8 mL). The reaction mixture was stirred at this temperature for 2h then at room temperature for 20h. After evaporation of the solvent under reduced pressure then with a high vacuum pump, the residue was dissolved in water (20 mL) and lyophilized to furnish a white solid (115 mg, 100% -2,6-bis[N,N-bis(tert-butoxycarbonylmethyl) amino methyl] pyridine (538 mg, 0.85 mmol, 1.0 eq.) was dissolved in 10 mL of CH 2 Cl 2 and the solution was degassed for 10 minutes by bubbling argon. Propargyl alcohol (150 L, 3.0 eq.) was added, then [CuCl(SIMes)(4,7-dichloro-1,10-phenan throline)]
ii (30 mg, 0.046 mmol, 5 mol-%) and the reaction mixture was stirred for 1h. Concentration in vacuum to half volume followed by filtration over silica with diethyl ether furnished a colourless oil. (460 mg, 0.66 mmol, 78% 3433, 2978, 2931, 2877, 1732, 1597, 1369, 1222, 1145, 756 . HRMS (ES+): calcd for C 34 H 55 N 6 O 9 : 691.4031, found 691.4029. b) Trifluoroacetic acid (8 mL) was added at 0°C to a solution of 4-(4-hydroxymethyl-1,2,3-1H-triazol-1-yl)-2,6-bis[N,N-bis(tert-butoxycarbonyl methyl)aminomethyl]pyridine (207 mg, 0.3 mmol) in dichloromethane (2 mL). The reaction mixture was stirred at 0°C for 2h then at room temperature for 20h. After evaporation of trifluoroacetic acid, the residue was dissolved in water (20 mL) and lyophilized to afford a white solid (191 1.3 Determination of the molecular weight of 2aH 4 x TFA and 2bH 4 x TFA. Since a variable amount of trifluoroacetic acid was noticed in the 2aH 4 and 2bH 4 samples after lyophilization, their apparent molecular weights were determined by 1 H NMR using 2,6-ditertbutyl-4-methylphenol (M = 220.3 g·Mol -1 ) as internal standard. The molecular weight M was determined using equation ( (1) where M, m and I are: the molecular weight, the measured weight and the aromatic proton signal integral, respectively. Experimental procedure. e.g. for 2aH 4 : 10.2 mg of the standard 2,6-ditertbutyl-4-methylphenol and 26.2 mg of 2aH 4 were dissolved in 1 mL of . The 1 H NMR spectrum was recorded and the aromatic signals integrals measured. The average of three independent experiments afforded an integrals ratio of 0.945 which resulted in an apparent molecular weight of 601±3 g·Mol -1 . This corresponded to the presence of 1.67 equivalents of trifluoroacetic acid.
Synthesis of activity-based probes 5, 6.
We synthesized the ABP 5 using typical Fmoc-Solid Phase Peptide Synthesis (SPPS). Besides the commercially available amino acids Fmoc-Leu-OH and Fmoc-Tyr(O-tBu)-OH synthesis of 5 required another three units: the alkyne modified glutamic acid 4, an epoxide moiety and a tetraethylene glycol spacer. Thus, compound 4 was obtained in a two-step sequence starting from Fmoc-Glu(O-tBu)-OH by an amide coupling reaction with propargyl amine in presence of HBTU/HOBt (HBTU :  O -benzotriazole-N,N,N',N'-tetramethyluroniumhexafluoro phosphate; HOBt : N-hydroxybenzotriazole) , as activating agents and DIPEA (N,N-diisopropyl ethylamine) as tertiary base followed by TFA mediated deprotection of the tert-butyl ester. The epoxide unit (ethyl (2R,3R)-trans-2,3-epoxysuccinate iii ) and the ethylene glycol spacer (14-N-Fmoc-amino-3,6,9,12-tetraoxa-1-tetradecanoic acid iv ) were obtained as previously described. Synthesis of ABP 5. alkyne-modified glutamic acid 4. a) tert-butyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(prop-2-yn-1-ylamino)pentanoate. To a solution of Fmoc-Glu-OtBu (1.00 g, 2.35 mmol) in anhydrous DMF, under argon, HBTU (872 mg, 2.30 mmol), HOBt (311 mg, 2.30 mmol) and DIPEA (910 mg, 7.06 mmol) were added and allowed to stir for five minutes, at room temperature. Propargyl amine (129.4 mg, 2.35 mmol) was then added and the reaction mixture was stirred at room temperature overnight. DMF was removed under vacuum and the oily residue was dissolved in dichloromethane (20 mL) and washed with water (2 x 20 mL). The organic phase was separated, dried over MgSO 4 , and evaporated. The residue was purified by column chromatography (silica gel, pentane/ethyl acetate v/v 1:1, Rf=0.54) to yield a pure, white product (1.01 g, 94 %). 7, 171.0, 156.5, 143.9, 143.6, 141.4, 141.3, 127.8, 127.1, 125.1, 120.1, 82.7, 79.5, 71.6, 67.0, 53.8, 47.2, 32.3, 29.3, 28.0 ((((9H-fluoren-9-yl) 
To a solution of tert-butyl 2-((((9H-fluoren-9-yl)methoxy)-carbonyl)amino)-5-oxo-5-(prop-2-yn-1-ylamino)pentanoate (1g, 2.16 mmol) in DCM (10 mL), trifluoroacetic acid (2 mL) and water (0.5 mL) were added and the reaction was allowed to stir for 3h at room temperature. The solvent was removed under vacuum and the reaction mixture was triturated SI 6 with diethyl ether. The precipitate was filtered to yield pure 4 (854 mg, 97 %).
1 H NMR (400 MHz, CDCl 3 ) δ (ppm): 7.77 (d, J = 7.2 Hz, 2H), 7.61 (d, J = 7.2 Hz, 2H), 7.40 (t, J = 7.2 Hz, 2H), 7. 2 (t, J = 6.9 Hz, 2H), 6.43 (br., 1H), 5.85 (br., 1H), 4.40 (d, J = 6.6 Hz, 2H), 4.35-4.27 (m, 1H), 4.22 (t, J = 6.6 Hz, 1H), 4.04 (s, 2H), 2.50 -2.13 (m, 4H), 2.06 (m, 1H).
13 C-NMR (126 MHz, DMSO-d 6 ) δ (ppm): 173.9, 171.3, 156.4, 144.1, 141.0, 127.9, 127.4, 125.6, 120.4, 81.5, 73.2, 65.9, 53.7, 46.9, 31.7, 28.1, 26.8 Compound 5 was synthesized by standard protocol for Fmoc Solid-Phase Peptide Synthesis using Rink amide MBHA resin (150 mg, loading capacity 0.7 mmol/g). The Fmoc protecting groups were removed by treatment with a 20% piperidine solution in DMF for 10 min twice. The amino acids were sequentially added using four equivalents of the amino acid with respect to the loading capacity and a ratio amino acid/HBTU/HOBt/DIPEA of 1:0.98:0.98:3 in DMF, except for the alkyne-modified glutamic acid and the tetraethyleneglycol-modified amino acid which were used only as 2 equivalents with respect to the resin loading capacity. Ethyl (2R,3R)-trans-2,3-epoxysuccinate (2 equiv) was coupled with DIC/HOBt (2:2 equiv) in DMF. The coupling reactions were quantitative between 1 to 3 hours as checked by qualitative Kaiser Tests. The resin was washed with DMF, MeOH and CH 2 Cl 2 . The peptide was cleaved from the resin using 1 mL of cleavage cocktail (95% TFA, 2.5% water, 2.5% triisopropylsilane) and allowing to shake for 2 hours. Ice cold ether was used to precipitate the product, which was analyzed by RP-C 18 -HPLC column using a linear gradient of 20-45% acetonitrile/water(0.1%TFA) for 15 minutes R t = 13.50 min, detection at λ = 230 nm and 280 nm, and purified on a corresponding preparative RP-C 18 -HPLC column, using the same gradient. Fractions containing the product were pooled, frozen and lyophilized to dryness to obtain 16.7 mg (17%) of pure peptide 5. Synthesis of ABP 6. 600 μL solution of ligand 1aH 2 (2.00 mg, 9.71 μmol) in methanol/water 1:1 and 400 μL solution of peptide 5 (8.00 mg, 8.45 μmol) in acetonitrile/water 2:8 were added in a 5 mL flask, under argon. Aqueous solutions of tris(3-hydroxypropyl triazolylmethyl)amine (THPTA) ligand (2.5 μL, 1mM), CuSO 4 (2.5 μL, 1mM) and sodium ascorbate (7.5 μL, 1mM) were sequentially added and the reaction mixture was stirred for 2h, at room temperature. The reaction was monitored by HPLC. The solvents were removed under vacuum and the product was purified by preparative RP-C 18 -HPLC using the same gradient elution method as for compound 5, R t = 14.23 min to obtain 6 in quantitative yield. Figure S1 . RP-C18-HPLC chromatograms of ABPs 5 (top) and 6 (bottom). UV detection at 230 nm. Linear gradient of 20-45% acetonitrile/water (0.1%TFA) for 15 minutes.
SI 2 -NMR study of yttrium(III) complexes
As a preliminary experiment, the SPAAC reaction between the diamagnetic yttrium(III) complex of 2a and BCN was evaluated by 1 H NMR (Figure below) . A fast and quantitative formation of the expected triazole occurred as inferred from the spectral modification -e.g. the shift of the pyridinyl protons (6.95 vs 7.43 ppm) . -5 mol, 1.1 eq.) were added, followed by 500 µL DMSO-d 6 . 1 H and 1 H, 13 C HSCQ NMR spectra were recorded. The AB system between 3.4 and 3.1 ppm is typical for methylene protons embedded in a chelate cycle. b) Starting from the above solution, 1.7 mg of bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN ) (1.13 mmol, 1.13 eq.) were added. The sample was vigorously shaken to dissolve BCN and the reaction was allowed to proceed for 5 minutes. 1 H, 1 H, 1 H-COSY 1 H, 13 C-HSCQ spectra were recorded. The spectra show a total disappearance of signals associated to the starting material. 
SI 3-Luminescence measurements

Instrumental parameters
Luminescence spectra were recorded in the phosphorescence mode with a Cary Eclipse fluorimeter. The spectra were recorded in 1 cm (or 0.2 cm for quantum yield determination) luminescence cells. The following parameters were used: gate time 1 ms, delay: 0.1 ms, total decay time 20.0 ms. The slits were set to 5/2.5 nm (excitation/emission) for complexes with 1a, 1b and 1c ligands and to 5/5 nm for the lanthanide(III) complexes with 2a, 2b and 2c ligands. The lifetimes were determined by recording the luminescence intensity at the maximum emission wavelength while incrementing the delay by 0.02 ms steps with a number of measurements adjusted to have the final delay > 3. Kinetic measurements were performed by recording each minute the luminescence intensity using optimum excitation and emission wavelengths of [Ln(2c)] -complexes. The solutions for luminescence measurements were prepared immediately before use as described below.
Preparation of lanthanide(III) complexes solutions
Lanthanide stock solutions Lanthanide(III) salts solutions, used as stock solutions for luminescence experiments, were prepared from the corresponding chloride salts (EuCl 3 ·6H 2 O, TbCl 3 ·6H 2 O) in distilled H 2 O. Their exact concentration was obtained by volumetric titration with a solution of EDTA (5 mM, Fisher Chemicals) in acetate buffer 0.1 M, pH = 4.5, using xylenol orange as colorimetric indicator.
Preparation of [Ln(1b) 3-solution prepared as above in a centrifugal vial. After ten minutes, the solution was diluted in 0.1 M Tris-HCl buffer for luminescence measurements.
Preparation of [Ln(2b)]
-solutions Having determined the apparent molecular weight for a given batch of 2bH 4 , we prepared a stock solution. Then, the appropriate volumes of Ln III salts and 2bH 4 stock solutions as well as Tris-HCl buffer (0.1 M, pH = 7.5) were added to prepare 3 mL solution, which was used for luminescence measurements.
Preparation of [Ln(2a)] -and [Ln(2c)] -solutions
A stock solution of 2aH 4 was prepared. 10 -5 mol of EuCl 3 or TbCl 3 (0.1 mL of a 10 -1 M stock solution), 2aH 4 (7.2 mg, 1.2×10 -5 mol, 1.2 eq.), 42.4 mg (4×10 -4 mol, 4.0 eq.) of sodium carbonate and 500 µL H 2 O were mixed and stirred in a centrifugal vial. Then, the resulting clear solution was diluted in 0.1 M Tris-HCl buffer for luminescence measurements (total volume: 3 mL).
1.32×10
-5 mol of BCN (2.0 mg, 1.1 eq. per azide function) were dissolved in 500 µL DMSO. This was added to 500 µL [Ln (2a)] -solution prepared as above. After ten minutes, the solution was diluted in 0.1 M Tris-HCl buffer for luminescence measurements (total volume: 3 mL). 
Speciation for for Ln-dpa systems.
The speciation diagram presented in figure S9 was computed using published v stability constants for the europium-dipicolinate system. This diagram shows that for 
Luminescence Decays
All decays, presented in Figures 
Quantum yield determination
Solutions of the europium-dpa, europium-1a and europium-1b at 7.5 10 -5 mol·L -1 and terbium-dpa, terbium-1a and terbium-1b at 6.5 10 -5 mol·L -1 were prepared in Tris-HCl buffer 0.1 M, pH = 7.5 using 250 mL volumetric flasks by weighing the appropriate amount of ligand and adding lanthanide stock solutions to obtain a 1:3 lanthanide/ligand stoichiometry. In this case, a mixture of bischelated and trischelated species is present in solution. 500 µl of each of these solutions was transferred to a fluorescence semi-micro cuvette (500 µL, 0.2 cm optical path length). Solutions of lanthanide complexes of 2a and 2b were prepared directly in the same cuvette by adding the appropriate volumes of lanthanide, ligand stock solutions as well as Tris-HCl buffer 0.1 M, pH = 7.5 to obtain 1.0·10
- For all these solutions, UV absorption spectra and emission spectra using  exc = 279 nm were recorded (figures below). Figure S24 . Electronic absorption spectra of europium(III)+ligand solutions used for quantum yield determination. Absorbance at 279 nm is highlighted. Figure S25 . Electronic absorption spectra of terbium(III)+ligand solutions used for quantum yield determination. Absorbance at 279 nm is highlighted. Figure S26 . Emission spectra of europium (III)+ligand solutions used for quantum yields determination. Figure S27 . Emission spectra of terbium (III)+ligand solutions used for quantum yields determination.
Each quantum yield (Q) was determined by applying equation (2) CH 2 C(O)OSu, 1.87M) was dissolved in 0.5 mL of DMF. Bovine Serum Albumin (BSA) (5.0 mg) was dissolved in 2.0 mL of borate buffer (pH = 7.9). The BCN solution was added dropwise to the protein at 0°C over one hour (if precipitation occurred during the addition, a few drops of DMF and borate buffer were added). The reaction was stirred overnight at room temperature then dialyzed (membrane cut-off 10kDa) against water and lyophilized to dryness to afford 5.8 mg of labeled protein.
MALDI-TOF-MS analysis
MALDI-TOF mass spectrum of BCN-BSA conjugate show the molecular ion peak at m/z= 74.1 kDa for the modified BSA corresponding to a mass increase of 7.5 kDa (as compared to BSA: 66.5 kDa). This corresponded to the addition of 18 cyclooctynes per BSA. 
SI 5 Papain labeling
5.1 General procedure for lanthanide complexation of peptide 6 and papain-6 conjugate. 36 μL solution of 6 (2 mM) in HEPES buffer (50 mM, pH=7, containing 5% DMSO) was treated with 7.2 μL of terbium(III) nitrate (10 mM) or europium(III) chloride (10 mM). The reaction was adjusted with buffer (6.8 μL) to a final volume of 50 μL and kept at room temperature for 1 h. The complexes were used in reactions with papain without isolation. A similar protocol was followed for lanthanide complexation of papain-6 conjugate with typical reactions involving 10 μL papain-6 conjugate (150 μM total protein concentration, and approximate 50 μM papain-6 conjugate concentration) in HEPES buffer (50 mM, pH=7) and 1μL terbium(III) nitrate (1.5 mM) or europium(III) chloride (1.5 mM) in HEPES (50 mM pH=7). The reactions were analysed by SDS-PAGE (12.5 % gel).
5.2
General procedure for the reaction between papain and peptide 5, peptide 6 or lanthanide complexes of 6. 25 μL Papain (250 μM total protein concentration, 75 μM active papain concentration) was added to 11 μL reaction buffer (HEPES 50 mM, DTT (dithiothreitol) 5 mM, pH=6.8) and incubated for 30 min. at room temperature Peptide 5 (4 μL, 1.8 mM) in DMSO : water (v/v) 1 : 4 was added and the reaction was kept at room temperature until no residual activity of papain was observed by UV-Vis measurements, using p-Glu-Phe-Leu-p-nitroanilide as chromogenic substrate (2 h). The reaction was filtered through a Microcon® YM-10 centrifugal filter (10 kDa MWCO) by centrifugation (14 000 rpm for 4 min) followed by three time washing with double distilled H 2 O. The resulting reaction mixture was analyzed by SDS-PAGE (12.5 % gel). A similar protocol was followed for the reactions of papain with peptide 6 as well as with terbium(III) or europium(III) complexes of 6 using 25 μL papain (250 μM total concentration, active papain concentration 75 μM) and 4 μL peptide 6 (1.8 mM) or 5 μL of lanthanide complexes of 6 (1.44 mM), in DMSO : water (v/v) 1 : 4, in a total reaction volume of 40 μL.
General procedure for the click reaction between ligand 1aH 2 (or complexes [Ln(1a) 3 ]
3-) and the alkyne-modified papain (papain-5 conjugate). 20 μL papain-5 conjugate (160 μM total protein concentration and approximately 48 μM papain-5 conjugate concentration) and 1 μL ligand 1aH 2 (3.2 mM) was added to 26.5 μL HEPES buffer (50 mM, pH=7). Aqueous solutions of CuSO 4 (1 μL, 3.2 mM), THPTA ligand (1 μL, 3.2 mM) and sodium ascorbate (1 μL, 9.6 mM) were then added. The reaction was allowed to rest at room temperature for 1 h, filtered through a Microcon® YM-10 centrifugal filter (10 kDa MWCO) by centrifugation (14 000 rpm for 4 min) followed by three times washing with ddH 2 O and analysis by SDS-PAGE (12.5 % gel). A similar protocol was followed for the reaction between complexes [Ln(1a) 3 ] 3-and papain-5 conjugate, with typical reactions involving 20 μL Papain-5 conjugate (160 μM total protein concentration and approximate 48 μM papain-5 conjugate concentration) and 1 μL solution of [Ln(1a) 3 ] 3-complexes (3.2 mM) in a total reaction volume of 50 μL.
Sensitivity of papain detection
We performed labeling of papain (30% active, as determined by E-64 active-site titration ix ) increasing concentrations (from 61.2 ng/μL to 612 ng/μL total protein concentration) with ABP 6. Since the ABPs are known to react only with active protein, ) were performed in presence of constant amounts of E. Coli BL21 cell lysates in reaction mixtures. a) 10 μL papain (30 μM, 45 μM and 60 μM respectively, total protein concentration), previously activated by 30 min. incubation in HEPES buffer (50 mM, pH=7) containing 5 mM DTT, was added to 20 μL E. Coli lysate. The reaction mixture was treated with 2 μL terbium(III) complex of 6 (173 μM, 260 μM and 390 μM, respectively) and the reaction was adjusted with buffer (18 μL) to a final volume of 50 μL. After 1 hour incubation at room temperature the reactions were analyzed by SDS-PAGE (12.5 % gel). b) 10 μL papain-5 conjugate (30 μM, 45 μM and 60 μM respectively, total protein concentration) was added to 20 μL E. Coli lysate and treated with 1 μL of [Tb(1a) 3 ] 3-(300 μM, 450 μM and 600 μM respectively), 1 μL CuSO 4 (300 μM), 1 μL THPTA ligand (300 μM) and 1 μL sodium ascorbate (1.5 mM) as described above. The reaction mixture was adjusted with buffer (16 μL) to a final volume of 50 μL and kept at room temperature for 1 h, then analyzed by SDS-PAGE (12.5 % gel).
